These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2936220

  • 1. [Experiences with the macrophage adherence inhibition test within the framework of preparing tumor-associated antigens from human breast cancers].
    Bendix U, Bendix U.
    Allerg Immunol (Leipz); 1985; 31(4):273-82. PubMed ID: 2936220
    [Abstract] [Full Text] [Related]

  • 2. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
    Kharkevich DD, Polevaia EB, Derevnina NA, Sablikova IuA, Savinov AIu.
    Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Pre- and postoperative reactivity of breast cancer patients to tumor associated antigens and HEP in the macrophage electrophoresis mobility (MEM) test].
    Ladusch M, Schäffner H, Ullmann L, Littmann M, Reimann S, Gindl P, Ambrosius H.
    Arch Geschwulstforsch; 1982; 52(6):469-78. PubMed ID: 6186223
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen.
    Fujino N, Haga Y, Sakamoto K, Egami H, Kimura M, Nishimura R, Akagi M.
    Jpn J Clin Oncol; 1986 Dec; 16(4):335-46. PubMed ID: 3467106
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Macrophage migration inhibition factor test in breast tumors.
    Gutman H, Kott I, Rabinerson D, Reiss R.
    Isr J Med Sci; 1986 Nov; 22(11):812-6. PubMed ID: 3793437
    [Abstract] [Full Text] [Related]

  • 11. The fundamental and diagnostic role of T and Tn antigens in breast carcinoma at the earliest histologic stage and throughout.
    Springer GF, Desai PR, Robinson MK, Tegtmeyer H, Scanlon EF.
    Prog Clin Biol Res; 1986 Nov; 204():47-70. PubMed ID: 2421349
    [No Abstract] [Full Text] [Related]

  • 12. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH, Holland JF, Bekesi JG.
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [Abstract] [Full Text] [Related]

  • 13. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y.
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [Abstract] [Full Text] [Related]

  • 14. [Human antitumor immunity according to leukocyte adherence inhibition test data].
    Riatsep VI, Kurtenkov OA, Nikitin IuG, Miliukhina LM.
    Vopr Onkol; 1980 Oct; 26(8):3-8. PubMed ID: 6998116
    [Abstract] [Full Text] [Related]

  • 15. [Expression of antigens immunologically related to the antigens of the mouse mammary tumor virus in the tissue of human breast tumors].
    Remennik LV, Litvinov SV, Kriukova IN, Chuev IuV.
    Biull Eksp Biol Med; 1985 Jun; 99(6):734-6. PubMed ID: 2990606
    [Abstract] [Full Text] [Related]

  • 16. [Immunologic studies using the leukocyte adherence inhibition test in the diagnosis and postoperative follow-up of breast cancer].
    Storch H, Granetzny A.
    Z Gesamte Inn Med; 1987 Jan 15; 42(2):41-4. PubMed ID: 3554795
    [Abstract] [Full Text] [Related]

  • 17. Superoxide assay-leukocyte adherence inhibition test and a soluble factor which stimulates the adherence of macrophages.
    Yagawa K, Kaku M, Manabe H, Yasumoto K, Mashiba H, Iribe H, Yamagata J, Takenaka K, Nomura Y.
    Cancer Res; 1980 Dec 15; 40(12):4791-5. PubMed ID: 6254653
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
    North SM, Steck PA, Nicolson GL.
    Cancer Res; 1986 Dec 15; 46(12 Pt 1):6393-9. PubMed ID: 3779654
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the LAI test in patients with benign and malignant breast diseases.
    Kovarík J, Lauerová L, Ninger E, Munzarová M, Feit J, Zemanová D, Wotke R.
    Neoplasma; 1983 Dec 15; 30(2):163-7. PubMed ID: 6843721
    [Abstract] [Full Text] [Related]

  • 20. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
    Nuti M, Castagna M, Squartini F.
    Appl Pathol; 1984 Dec 15; 2(3):117-27. PubMed ID: 6085790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.